Bank of America Corporation »

Crispr Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $51M 1.1M 46.98
2024-06-30 $57M 1.1M 54.01
2024-03-31 $71M 1.0M 68.16
2023-12-31 $54M 860k 62.60
2023-09-30 $31M 680k 45.39
2023-06-30 $43M 768k 56.14
2023-03-31 $23M 518k 45.23
2022-12-31 $17M 427k 40.65
2022-06-30 $104M 1.7M 60.78
2021-12-31 $56M 735k 75.78
2021-06-30 $174M 1.1M 161.88
2021-03-31 $55M 453k 121.88
2020-12-31 $54M 352k 153.17
2020-09-30 $5.9M 71k 83.62
2020-06-30 $5.8M 78k 73.54
2020-03-31 $2.7M 63k 42.43
2019-12-31 $2.9M 47k 60.84
2019-09-30 $3.2M 78k 40.98
2019-03-31 $1.3M 35k 35.73
2018-12-31 $164k 5.7k 28.66
2018-06-30 $553k 9.4k 58.80
2018-03-31 $340k 7.4k 45.66
2017-12-31 $234k 10k 23.33
2017-09-30 $223k 13k 17.86
2017-03-31 $316k 15k 21.77
2016-12-31 $436k 22k 20.28